It appears that CA IX is only a weak, nonindependent prognostic marker, because correction for apparently stronger prognostic markers such as positive nodes, tumour size, malignancy grade, hormone receptor status, HER2 status, menopausal status/systemic treatment and randomization eliminated the effect of CA IX status. The gene discussed is NR4A1; the disease is neoplasm.